The failure of signal transduction in the JCaM1 cell line was associated with the presence of an abnormal lck mRNA deleted of the exon 7 encoding for an inactive p56 lck kinase. Our study of the lck mRNA from various T cell lines and from peripheral blood lymphocytes of healthy donors has revealed the presence of both complete and exon 7-deleted lck transcripts. Thus the exon 7-deleted lck transcript initially described in the JCaM1 mutant cell line, arises from an alternative splicing event occurring in each cells expressing the lck gene. Genomic DNA sequencing of the lck exons 6 ± 8 portion from both the mutant JCaM1 and its parental Jurkat cell lines revealed as the only dierence, the presence of a A to G mutation within the 5' splice site of intron 7 in the JCaM1 cell line DNA. To demonstrate the role of this point mutation in the lck pre-mRNA maturation, COS cells were transfected by lck minigenes from the Jurkat and JCaM1 cell lines. In COS cells transfected with minigene from the Jurkat cell line both lck transcripts (with and without exon 7) were observed whereas only the exon 7-spliced lck transcript was observed in COS cells transfected with minigene from the JCaM1 cell line. Thus the mutation is per se responsible for the deletion of exon 7 and the absence of complete lck mRNA in the JCaM1 cell line. Presence of a restriction site (HphI) in the 5' splice site of lck intron 7 from Jurkat DNA allowed to con®rm the presence of the mutation on both alleles in the JCaM1 cell line.
Introduction
The lck gene is a member of the src family of genes comprising ten well-characterized members which encode highly conserved non-receptor protein tyrosine kinases (PTKs): Src, Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk, Yrk and Rak (Cooper et al., 1990; Sudol et al., 1993; Cance et al., 1994) . The product of the lck gene is a 56 kDa protein which is predominantly expressed in T lymphocytes (Voronova et al., 1985) and plays a key role in the signal transduction following the antigen/Tcell receptor (TcR) interaction. Indeed, stimulation of T cells by antigen or anti-TcR antibodies leads to a rapid rise of intracellular tyrosine protein phosphorylation but none of the TcR chains exhibit intrinsic kinase activity (Hsi et al., 1989) . The p56 lck is the PTK which triggers the initial phosphorylation events on conserved tyrosine residues in the immunoreceptor tyrosine-based activation motif (ITAM) of the CD3 zeta chain (Van Oers et al., 1996) . This is followed by recruitment of ZAP-70, a protein tyrosine-kinase of the Syk family (Isakov et al., 1995) and the progression of the phosphorylation-activation cascade. Involvement of the p56 lck in this process is possible owing to both its membrane anchorage (via myristoylation of the Nterminal GLY residue) and its association with the intracellular domain of the coreceptors CD4/CD8 cell surface antigens (Veillette et al., 1988) . This association involves a pair of cysteine residues both in p56 lck and CD4 molecules (Turner et al., 1990) . Previously we reported the existence of an alternative splicing of the ®rst lck exon (which contains the ATG initiating codon and the CD4 binding site) with conservation of the open reading frame (ORF) (Rouer and Benarous, 1992) . This alternative lck transcript leads to an Nterminal modi®ed p56 lck but, the isoform lacking the consensus sequence to both anchorage to the membrane and association to CD4, we could expect that localization of p56 lck and some of its biological functions would be modi®ed. Indeed, we observed that this isoform exhibits a cytoplasmic instead of membrane localization and leads to a modi®ed phosphorylation pattern of cellular proteins (Rouer, unpublished data) .
The alternative splicing is a widely used mechanism to produce multiple protein-coding sequences from the same mRNA precursor. Presence of isoforms in the same cell or in dierent cells, is a mean to achieve a precise and speci®c regulation of dierent functions supported by a common biochemical mechanism. A variety of alternative splicing patterns have already been reported for several members of the src gene family. The c-src gene displays a neuron-speci®c alternative splicing leading to transcripts encoding a c-src protein with 17 additional amino acids within the SH3 domain (Pyper and Bolen, 1990) . This isoform exhibits an elevated tyrosine kinase activity and altered transforming capacity as compared with the nonneuronal form (Levy and Brugge, 1989) . The lyn gene exhibits two transcripts (lyn A and lyn B), which arise from an alternative use of an internal donor splice site (Stanley et al., 1991) . They lead to isoforms which interact dierently with the B-cell antigen receptor (Yamanashi et al., 1991) . The fyn gene displays a mutually exclusive splicing of exons 7A and 7B, in a tissue-speci®c manner leading to p59 fynB and p59 fynT isoforms exhibiting a dierent enzymatic activity (Cooke and Perlmutter, 1989).
The presence of an abnormal lck transcript lacking exon 7 has been reported in the mutant JCaM1 cell line (Straus and Weiss, 1992) . Since exon 7 contains the ATP binding site (Carrera et al., 1993) its absence in this abnormal lck transcript explains the lack of kinase activity and the absence of normal signal transduction following TcR stimulation. In the present work we attempted to elucidate the mechanism responsible for such an abnormal lck mRNA lacking exon 7. We ®rst examined dierent RNAs from cells expressing the lck gene to know whether this was a speci®c ®nding occurring exclusively in the mutant JCaM1 cell line or whether it could be relevant of the general alternative splicing process. We demonstrated that loss of exon 7 is indeed a general process arising by alternative splicing in every cell expressing the lck gene. We were also interested in the detection of possible mutations within the lck gene which could explain the occurrence of the exon 7-spliced lck transcript as the sole lck transcript in the JCaM1 cells. Finally, we report that a single-point mutation in the 5' splice site of intron 7 is responsible for the absence of complete lck transcript in the mutant JCaM1 cell line.
Results
Both complete and exon-7 deleted lck mRNAs are together produced in all cells expressing the lck gene First of all the presence of an exon 7 deletion in lck transcripts was investigated in the Jurkat cell line, the T-cell line from which the JCaM1 is derived. This was realized by reverse transcriptase ± polymerase chain reaction (RT ± PCR), using forward and reverse primers located in exons 6 and 9 respectively. Fragments of 424 and 271 bp in size are expected according to the presence or the absence of exon 7. In RNA from the Jurkat cell line both fragments are observed, whereas a single fragment of 271 bp is obtained from RNA of the JCaM1 cell line ( Figure  1b) . We further examined the exon 7 skipping in RNAs from other T-cell lines (Cem, Ke37 and Molt-4) and from peripheral blood lymphocytes (PBLs) of healthy donors. Both fragments of the expected size are observed (Figure 1c ). DNA sequencing con®rmed that the 271 bp fragment diers from the 424 bp only by the absence of the exon 7 sequence. The absence of exon 7 results in the juxtaposition of exons 6 and 8, with conservation of the Lck open reading frame. However such junction between exons 6 and 8 leads to the AGG codon, which encodes a new aminoacid ARG in place of GLY at the beginning of exon 8 (Figure 1a) .
Expression of the human lck gene occurs predominantly, but not exclusively, in T cells. Signi®cant amounts of lck mRNA have been also detected by Northern blot analysis in some transformed B-cell lines (Jucker et al., 1991) and in some carcinoma cell lines (Veillette et al., 1987) , so we examined by similar RT ± PCR analysis, the presence or the absence of exon 7 in these RNAs. Both PCR fragments were observed in the B-cell lines Daudi and Raji, though they are produced to a much weaker level than in the T-cell lines (data not shown). In these B cell lines, the low level of the PCR fragments is in correlation with the level of lck transcripts expressed in these cell lines (Perlmutter et al., 1988) and which arise from the type I promotor only (Rouer et al., 1994) . In the SW480 colon carcinoma cell line, both PCR fragments are easily detectable (data not shown).
These results demonstrate that the absence of exon 7 in lck mRNA from the JCaM1 cell line, previously reported by Straus and Weiss, is also observed in cells expressing the lck gene and results from a generalized splicing taking place, even in transformed or normal cells and in PBLs. In these cells (except in the JCaM1 cells), the abnormal splicing leading to loss of exon 7, arises together with the normal splicing which removes introns 6 and 7. Thus this abnormal splicing event corresponds in fact to an alternative splicing mechanism. By contrast in the JCaM1 cell line, the remarkable feature is the absence of a normal splicing of introns 6 and 7, leading to the absence of a complete lck transcript rather than the presence of an exon 7-deleted lck transcript.
The lck exon 7-spliced transcript is a correctly initiated and full-length transcript Expression of the lck gene is governed by two widely separated promoters (Takadera et al., 1989) . We wondered whether the exon 7-spliced transcript is indeed a correctly initiated and a full-length mRNA. RT ± PCR was performed with a reverse primer located at the end of exon 12 (the last exon) and a forward primer located either in exon 1 or exon 1' to check if these transcripts are correctly initiated at each promotor. With a 5' primer located in exon 1' (region of the type I promotor), the expected size of the ampli®ed fragments with and without exon 7 are 1378 and 1225 bp respectively. PCR products were analysed on a 2% agarose gel, after blotting and hybridization with oligonucleotide probes speci®c for either exons 7 or 8, the identity of these fragments were con®rmed (Figure 2 ). With the forward primer located in the exon 1 region of the type II promotor, similar results con®rm also the occurrence of two full-length lck transcripts with and without exon 7 (data not shown).
A single-point mutation in lck intron 7 distinguishes the JCaM1 lck gene from the Jurkat one The JCaM1 cell line is derived from the Jurkat cell line and was observed to have an altered signal transduction capacity (reduced phosphatidylinositol metabolism and calcium mobilization) in response to TcR stimulation, despite the expression of structurally normal CD3/TcR complexes (Straus and Weiss, 1992) . This defect was correlated to the absence of active p56
lck resulting from the lack of exon 7 in lck transcripts present in this cell line. To elucidate the molecular mechanism responsible for the absence of complete lck transcript, we puri®ed its genomic DNA and performed sequence analysis on the ampli®ed introns 5 ± 8 portion.
Ampli®cation of genomic DNA from JCaM1 and Jurkat cells were performed using forward and reverse primers annealing respectively within the lck introns 5 and 8 sequence. A 982 bp fragment was obtained, puri®ed and sequenced. The only dierence found in this portion of the lck gene between JCaM1 and Jurkat DNAs was an A in Jurkat replaced by a G in JCaM1 within the 5' (donor) splice site of intron 7, at position +4 (Figure 3 ). The 5' splice site sequence in the Jurkat cell line is GTGAG, and in the JCaM1 cell line this splice site if GTGGG. The absence, at this position, of mixed-base, either in Jurkat or in JCaM1, suggests that both alleles are homozygote in each cell line.
Analysis of the A ± G homozygote mutation in JCaM1 cells by restriction pattern of its genomic DNA Sequence of the 5' splice site in the Jurkat cell line GGTGAG, corresponds to an HphI restriction site, and the A ± G mutation abolished this HphI site. The existence of such a restriction site within the Jurkat sequence is a useful tool to con®rm the homozygote status. Thus we performed HphI digestion on the According to the restriction map, nine HphI sites are present in the lck fragment introns 5 ± 8 from the Jurkat cell line leading to ten fragments (209, 175, 110, 107, 93, 91, 69, 55, 40 and 33 bp) . The mutation abolishes one site, resulting in the absence of both the 175 and 55 bp fragments, which are replaced by a longer one of 230 bp (scheme Figure 4a) . The HphI digestion products were radiolabelled then separated on a 5% acrylamide gel (see Figure 4b ). In the DNA fragment ampli®ed from the JCaM1 cell line, the 230 bp fragment was observed and no fragments of 175 and 55 bp were detected. By contrast, the 175 and 55 bp fragments were detected in the Jurkat ampli®ed product but no fragment of 230 bp was observed. This result con®rms the presence of the A ± G mutation on both alleles of the JCaM1 genomic DNA.
The A ± G mutation impairs the intron 7 splicing in COS cells transfected by JCaM1 lck minigene Since the only signi®cant sequence dierence concerning the lck exons 6 ± 8 portion between the Jurkat and JCaM1 cell lines lies in the 5' splice site of intron 7 (Figure 3 ), this mutation is likely responsible for the absence of normal splicing in JCaM1 cells. In order to check this hypothesis we constructed lck minigenes (from exons 6 ± 8) from both Jurkat and JCaM1 cell lines in the pCDNA1 expression vector and we used them in transient transfections of COS cells. If the A ± G mutation in JCaM1 minigene is per se responsible for the absence of intron 7 splicing, we should obtain only one lck transcript (without exon 7) in transfected cells, whereas two lck transcripts should be obtained in cells transfected with the Jurkat minigene. + RNA from the Molt-4 cell line and ampli®cation was performed with a forward primer located in intron 1, from nt 227 to 248 according to the numbering of the lck gene sequence (Rouer et al., 1989) , and a reverse primer located in exon 12, from nt 1410 to 1390, according to the numbering of the lck cDNA (Perlmutter et al., 1988) . Ampli®cation was performed as indicated in Materials and methods excepted the extension step which was performed for 90 s. PCR products were analysed on a 2% agarose gel. Two identical gels were performed and blotted onto nylon membrane The HphI digests were resolved on a 4% acrylamide gel in TBE buer. MW : 5' radiolabelled DNA molecular weight marker. Gel was dried and autoradiographed COS cells were transfected with each lck minigene (scheme Figure 5a) and analysis of the lck RNAs produced in transfected COS cells was performed by RT ± PCR using forward and reverse primers respectively in the exons 6 and 8 sequence. Fragments of 298 and 145 bp should be ampli®ed respectively from lck RNA normally spliced of both introns 6 and 7, and from exon 7-spliced lck RNA (see Figure 5b ). COS cells transfected by the JCaM1 lck minigene gave rise to a single and intense fragment of 145 bp (lane 1), whereas COS cells transfected by the Jurkat lck minigene gave rise to a fragment of 298 bp together with a 145 bp fragment (lane 2). None of these fragments were obtained from RNA of COS cells transfected by the pCDNAI vector alone as a negative PCR control (lane 3). Both fragments were puri®ed and sequenced to check their identity. DNA sequence con®rms the predicted molecular structures, thus the presence of the A ± G muation in the 5' splice site of intron 7 is per se responsible for the absence of normal intron 7 splicing as the consequence of the impairment of the ®rst step of the splicing event, the cleavage at the 5' splice junction.
Discussion
In this paper we demonstrated that the exon 7 deletedlck transcript reported in the mutant cell line JCaM1, can also be observed in every lck expressing cells and arises from an alternative splicing mechanism. We also demonstrated that the exon 7 spliced lck transcript is a full-length transcript initiated at both promotors, as does the complete lck transcript, so that an isoform may be produced. Straus and Weiss (1992) indeed detected the presence of a lower molecular weight protein in Western blot analysis which could correspond to this isoform. Since the exon 7 sequence encodes the beginning of the catalytic domain (mainly the GXGXXG motif constituting the ATP-binding site) (Carrera et al., 1993) , its absence will impair any kinase activity of this isoform. By sequence analysis of the exon 6/intron 7 boundary of genomic DNA from JCaM1 cells, we detected the presence of a A ± G point mutation in the 5' splice site of intron 7. Intron removal is a two-step process involving ®rst a cleavage at the 5' splice junction with a concomitant religation of the free 5' end to the 2' hydroxyl of a speci®c adenosine residue within the branchpoint of the intron. These reactions are carried out by a large catalytic complex, the spliceosome. Assembly of the spliceosome involves a set of particules or small nuclear ribonucleoproteins (snRNPs) (Guthrie and Patterson, 1988) and numerous splicing factors such as the SR proteins (Zahler et al., 1992) which are thought to help recruit the U1 snRNP to the 5' splice site of the pre-mRNA (Jamison et al., 1995) . The U1 snRNP binds at the 5' splice site via RNA : RNA base-pairing. The A to G mutation we report here, located in +4 within the consensus splice site, may aect the correct basepairing and, as a consequence, the functional interactions between the components of the spliceosome. In fact analysis of the frequencies of each of the four nucleotides at each position deduced from more than a thousand donor splice sites, reveals the presence of A at position +4 in 71% of the cases, whereas G is only present in 12% of the compiled donor splice sites (Burge and Karlin, 1997). Thus the A to G mutation at position +4 in JCaM1 DNA may introduce a destabilizing base of the pre-mRNA : U1snRNp base pairing. Numerous studies have reported splicing defects leading to either absence or reduction of the mature mRNA. In particular the study by Krawczak et al. (1992) reports more than 100 point mutations in the vicinity of exon/intron splices junctions which result in such splicing defects. Among these mutations, 60% take place at the 5' splice site and more than half lead to exon skipping. Thus in the JCaM1 DNA, the inability to initiate the correct excision of intron 7 at the 5' splice site could explain the absence of complete lck transcript: the exon 7 is no longer recognized as such and is thereby excluded from the mature mRNA. In agreement with Krawczak et al. (1992) who observed that it is always the upstream exon immediately preceding the defect that was removed from the mature mRNA, we reported here that exon 7 is skipped as a consequence of a point mutation in intron 7. By means of COS cells transfected with minigenes from the Jurkat or JCaM1 cells, we could indeed demonstrate the critical role played by this mutation in the splicing mechanism. We thus have identi®ed the genetic defect present in the JCaM1 cell line responsible for the de®ciency of functional p56 lck . The exon 7-spliced lck may not be considered as an abnormal transcript since it is relevant of the alternative splicing mechanism also observed in normal lymphocytes from peripheral blood sample. Since this exon 7-spliced Lck isoform has conserved all of the domains of the p56 lck including SH2, SH3 as well as the CD4 binding site, it could behave as a natural regulator (negative transdominant) limiting the extent of the tyrosine phosphorylation. Alternatively, since Xu and Littman (1993) The primers used were located in exons 6 and 8, respectively from nt 642 ± 662 and nt 938 ± 916 according to the numbering of the lck gene sequence (Rouer et al., 1989) . MW : DNA molecular weight marker V kinase activity of p56 lck , this exon 7-deleted isoform could ful®l these functions which do not require kinase activity.
Materials and methods
Cell culture and DNA transfection T-cell lines and COS-7 cells were grown respectively in RPMI 1640 and DMEN media supplemented with 10% foetal calf serum, 10% L-glutamine and 10% penicillin-streptomycin (GIBCO ± BRL). Cells were transfected using the ExGen reagent (Euromedex) as a gene-delivering agent and 2 ± 5 mg of plasmid DNA. Transfected cells were harvested 48 h later.
Genomic DNA and RNA extractions
Genomic DNA and total RNA from cell lines were extracted using respectively the Wizard Genomic DNA Puri®cation kit (Promega) and the High Pure RNA Isolation kit (Boehringer). Poly(A) + RNA was extracted using the mRNA Puri®cation kit from Pharmacia.
Reverse transcriptase ± polymerase chain reaction (RT ± PCR) 1 ± 2 mg of total RNA was reversed transcribed (RT) in 20 ml ®nal volume as previously reported (Rouer et al., 1993) . Then 1 ml of the RT reaction was used in a 100 ml ampli®cation mixture using Taq DNA polymerase (2.5 units) buer and MgCl 2 (2 mM ®nal concentration) from GIBCO ± BRL and 0.2 mM of each dNTP (Pharmacia). The enzyme was added just after the initial denaturation (948C for 2 min) which was followed by 30 cycles consisting of hybridization (608C for 40 s), extension (728C for 30 s) and denaturation (948C for 30 s). Ten ml of each reaction was analysed on a 2 or 4% agarose gel. Dierent sets of primers were used according to the experiment and they are detailed in ®gure legends. PCR fragments of interest were excised from ethidium bromide stained agarose gel then DNA was extracted using the Prep-A-Gene DNA Puri®cation system (BIO-RAD). Puri®ed DNA was submitted to sequence analysis using the DYE Terminator kit (Perkin Applied Biosystem) and the Automated Sequencer 373A.
Southern blot analysis
PCR products were separated on an agarose gel, denatured by soaking for 30 min in 0.5 N NaOH, 1.5 M NaCl solution, neutralized for 30 min in 1 M Tris-HCl pH 7.4, 1.5 M NaCl then transferred by capillarity onto a nylon membrane in 106SSPE. Membranes were prehybridized for 15 h at 528C in 66SSPE, 0.1% SDS, 56Denhardt reagent and 40 mg/ml of sheared herring sperm DNA. Speci®c oligonucleotide probes of either exon 7 or exon 8 were located respectively from nt 742 to 722 (TCTGGGGCTTCTGGGTCTGGC) and from nt 938 to 916 (TTGCAGCTGCTTCAT-GAGGTTGGC). They were 5' labelled and hybridization was carried out at 528C over night. Membranes were washed in 26SSPE, 0.1% SDS at 528C for 90 min then in 0.56SSPE, 0.1% SDS at 528C for 15 min.
Minigene constructions in the pCDNAI expression vector
Ampli®cation of a portion of the lck gene from both Jurkat and JCaM1 cell line DNAs was performed using primers located in introns 5 and 8 from nt 1870 to 1891 and nt 2840 to 2816 respectively according to the numbering of the lck gene (Rouer et al., 1989) . These primers have been designed with a 5' restriction site (respectively BamHI and EcoRI) for subcloning into the pCDNA I vector (InVitrogen). These PCR fragments of 982 bp were puri®ed then used as templates for a second round of ampli®cation, with nested primers annealing in exons 6 and 8 located respectively from nt 1943 to 1959 and nt 2707 to 2690. Bacteria MC1061/P3 were transformed and grown in the presence of ampicillin (12.5 mg/ml)+tetracycline (7.5 mg/ml). Plasmid DNAs were puri®ed using the QIAGEN plasmid kit.
HphI incubation and analysis
The 982 bp fragments corresponding to ampli®cations of the introns 5 ± 8 lck gene from Jurkat and JCaM1 genomic DNAs, were puri®ed by migration on agarose gel and extraction using the Prep-A-Gene kit. About 100 ng were incubated with 20 units of HphI (USB) for 3 h at 378C. Incubations were then treated by phenol/chloroform. The 5' ends were labelled with gP-32 ATP using 5 units of the T4 polynucleotide kinase with the exchange buer (GIBCO ± BRL) for 30 min at 378C. Reaction was stopped by addition of 5 mM EDTA. DNA fragments of the molecular weight marker V were similarly labelled. HphI incubations were resolved on a 4% acrylamide gel.
